— Know what they know.
Not Investment Advice

EGRX Institutional Ownership

Eagle Pharmaceuticals, Inc.
1W: -79.4% 1M: -77.0% 3M: -68.7% YTD: -38.2% 1Y: -92.2% 3Y: -98.6% 5Y: -99.6%
$0.21
-0.75 (-78.12%)
 
Weekly Expected Move ±358.9%
$-1 $-1 $0 $1 $2
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 48 · $2.8M mcap · 11M float · 0.044% daily turnover · Short 12% of daily vol

Institutional Ownership — EGRX

2
Institutional Holders
+0 vs prior quarter
0.0%
Ownership
+0.00pp
$0M
Total Invested
0
New Positions
0
Increased
0
Reduced
0
Closed
0.00
Put/Call Ratio

Ownership Trends

Top Institutional Holders (2 total)

# Holder Shares Value Change Change % Holding Period Filing
1 Stanley-Laman Group, Ltd. 12,000 $$3K — +0.0% 48Q SEC ↗
2 Archer Investment Corp 350 $$0K — +0.0% 14Q SEC ↗

Recent Activity

New Positions (0)

No new positions this quarter.

Sold Out (0)

No sold-out positions this quarter.

Biggest Increases (0)

None.

Biggest Decreases (0)

None.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms